Ua ʻike ʻia kahi noiʻi preclinical hiki ke kōkua ʻia ʻo CBD no ke kōkua ʻana i ka hoʻihoʻi ʻana a me ka hōʻemi ʻana i ka hopena lōʻihi o kahi hōʻeha lolo. | ʻAiole

Ua lawe ʻia ka noiʻi holoholona e nā ʻepekema mai ka Center for Research and Advanced Studies of Neurological Diseases ma ka Siglo XXI National Medical Center ma kahi huahana CBD proprietary i hana ʻia e ka hui US HempMeds.

Ua ʻōlelo ka hui ma kahi hoʻolaha paʻi ua hōʻike nā mea noiʻi i ka hoʻokele waha o CBD i hiki ke hōʻemi i ka hoʻokuʻu nui ʻana o ka glutamate i loko o ka cerebral cortex e hiki ai ke alakaʻi i ka TBI.

ʻO Glutamate ka neurotransmitter excitatory nui o ka ʻōnaehana nūnū waena.  ʻO nā kiʻekiʻe kiʻekiʻe o ka glutamate e alakaʻi i kahi kaʻina i kapa ʻia he excitotoxicity, hiki ke alakaʻi i ka make o nā neurons.

Ua alakaʻi ʻo Dr Luisa Rocha i ke aʻo ʻana, i hui pū me kahi hui o nā ʻepekema Mekiko.

"Ma o kēia aʻo ʻana, ua hiki iā mākou ke ʻike i ka hoʻokele waha o cannabidiol i nā lā ʻehiku ma mua o kahi hōʻeha i kōkua i ka pale ʻana i ka hoʻokuʻu nui ʻana o ka glutamate i hopena mai ka trauma lolo, kahi hopena e pili ana i ka emi ʻana o ka make ma nā neurons," Ua wehewehe ʻo Dr Rocha.

"Ma kēia noiʻi ʻana, ua hōʻike pū ʻia ka noi ʻana o CBD e kōkua i ka hoʻomaikaʻi ʻana i ka sensorimotor."

Ua hoʻohui ʻo Dr Rocha: "ʻO nā hopena i loaʻa i kēia haʻawina e kōkua i ka hoʻomaopopo ʻana i ke ʻano o ka noi waha o cannabidiol e hōʻemi ai i ka excitotoxicity i hoʻokumu ʻia e nā ʻeha lolo traumatic lōʻihi a hoʻomaʻamaʻa i ka hoʻōla hana. 

"ʻO ka ʻoiaʻiʻo, ua lawa ka mālama ʻana ma mua o ka hōʻeha CBD e hōʻemi i ka hopena o ka hōʻeha lolo traumatic."

Ua hana ʻia ke aʻo ʻana me ka hoʻohana ʻana i ka huahana RSHO hae nui o HempMeds, nona ka 0% THC, a me kahi kiʻekiʻe o ka CBD waiwai nui.

ʻO ka hui, nona ka Medical Marijuana Inc, i hui pū ʻia ma kahi noiʻi e hōʻike i ka maikaʻi o ka hemp-based CBD i ka mālama ʻana i ka maʻi o Parkinson.  

Ua ʻōlelo ʻo Blake Schroeder, Luna Hoʻokele o Medical Marijuana Inc: "ʻO ka hōʻoia ʻana i ka hiki ke therapeutic o CBD ma ke kumu o kā mākou ʻoihana a me nā hopena o kēia noiʻi e hōʻike hou ana i ka waiwai therapeutic o CBD kumulāʻau.

"Ma o kā mākou mau noiʻi noiʻi ke hoʻomau nei mākou i ka hōʻike ʻana pehea e hiki ai i ka CBD ke hoʻopilikia maikaʻi i nā maʻi ma ka honua holoʻokoʻa.  

"ʻOiai ua lohi nā keʻena noiʻi i hoʻopaʻa kālā ʻia ma ka US i ka noiʻi ʻana i ka cannabis, ua hana nā hui ʻAmelika Latin i kēia ʻano noiʻi me kā mākou Hui no nā makahiki.  

"E hoʻomau mākou i ka noiʻi ʻana ma Mexico a me Brazil, kahi mākou e ʻimi nei i ka hoʻopaʻa inoa lāʻau o kā mākou huahana."

Cannabis a me Neuroprotection 

Me he mea lā e paʻa nui nā cannabinoids i ka wā e pili ana i ka neuroprotection.

Ua mālama ʻia kekahi mau haʻawina e pili ana i kona hoʻohana ʻana i ka mālama ʻana i ka maʻi Alzheimer a me ka maʻi Parkinson, me nā hopena maikaʻi.

I ka makahiki i hala, ua ʻike ʻia kahi haʻawina e hiki i ka THC ke kōkua i ka poʻe i loaʻa i ka TBI e hoʻihoʻi hou i kā lākou hoʻomanaʻo hana a me ka hana kaʻa.

Ua hāʻawi pū ka US National Football League (NFL) i kahi kālā noiʻi US $1 miliona e nānā i nā hopena o nā cannabinoids i ka hoʻokele ʻeha a me ka neuroprotection mai ka concussion i ka pôpeku elite.

ʻO kahi noiʻi hoʻomau e manaʻo e loiloi i nā waiwai neuroprotective o cannabinoids e hōʻemi i ka paʻakikī o ka concussion acute a me ka maʻi i nā mea pāʻani pôpeku.

  • Hoʻoikaika ʻo THC i ka hoʻihoʻi ʻana mai ka ʻeha o ka lolo traumatic, ʻike ʻia ka noiʻi
  • No ke aha e pono ai ka noiʻi hou aku i nā hopena o ka cannabis i ka hōʻeha lolo
  • Hiki i nā Cannabinoids ke kōkua i ka hoʻopaʻa ʻana i ka pōʻino lua o nā TBI
  • Kōkua ka cannabis lapaʻau i ka hoʻomaikaʻi ʻana i ka hiamoe i nā poʻe maʻi me PTSD - aʻo

Hōʻike ka haʻawina e hiki i nā hui cannabinoid Gb Sciences ke mālama i ka maʻi Parkinson.


Ka manawa hoʻouna: 06-25-2023

Huahanawaeʻano

Waiho i kāu leka

    *Inoa

    *leka uila

    Kelepona/WhatsAPP/WeChat

    *He aha kaʻu e ʻōlelo ai